Intervention Review

Gemcitabine for unresectable, locally advanced or metastatic bladder cancer

  1. Mike Shelley1,*,
  2. Anne Cleves2,
  3. Timothy J Wilt3,
  4. Malcolm Mason4

Editorial Group: Cochrane Urology Group

Published Online: 13 APR 2011

Assessed as up-to-date: 12 JUL 2010

DOI: 10.1002/14651858.CD008976.pub2


How to Cite

Shelley M, Cleves A, Wilt TJ, Mason M. Gemcitabine for unresectable, locally advanced or metastatic bladder cancer. Cochrane Database of Systematic Reviews 2011, Issue 4. Art. No.: CD008976. DOI: 10.1002/14651858.CD008976.pub2.

Author Information

  1. 1

    Velindre NHS Trust, Cochrane Prostatic Diseases and Urological Cancers Unit, Research Dept, Cardiff, Wales, UK

  2. 2

    Cardiff University Velindre Hospital, Cancer Research Wales Library, Cardiff, Wales, UK

  3. 3

    VAMC, General Internal Medicine (111-0), Minneapolis, Minnesota, USA

  4. 4

    Velindre Hospital, Clinical Oncology, Cardiff, UK

*Mike Shelley, Cochrane Prostatic Diseases and Urological Cancers Unit, Research Dept, Velindre NHS Trust, Velindre Road, Whitchurch, Cardiff, Wales, CF4 7XL, UK. mike.shelley@velindre-tr.wales.nhs.uk.

Publication History

  1. Publication Status: New
  2. Published Online: 13 APR 2011

SEARCH